Oncolytic Virotherapy Market Size, Trends, Analysis, and Outlook By Type (HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Others), By Application (Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Others), by Country, Segment, and Companies, 2024-2032
The global Oncolytic Virotherapy market size is poised to register 24.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Oncolytic Virotherapy market across By Type (HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Others), By Application (Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Others)
With the increasing demand for innovative cancer treatments and personalized medicine, there is a rising interest in oncolytic viruses as a novel therapeutic approach to target and destroy cancer cells while sparing healthy tissue. Market growth is driven by factors such as expanding cancer incidence and prevalence, the rising investment in immuno-oncology research and development, and technological advancements in viral vector design and gene editing techniques. Additionally, the expanding applications of oncolytic virotherapy in solid tumors, hematological malignancies, and combination therapy regimens, as well as the growing number of clinical trials and regulatory approvals, contribute to market expansion. Further, the development of tumor-targeted viral vectors and immune-modulating strategies, the integration of oncolytic viruses into standard-of-care treatment protocols, and the emphasis on patient selection and biomarker-driven therapy are expected to further accelerate market growth in the coming years.
Oncolytic Virotherapy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Oncolytic Virotherapy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Oncolytic Virotherapy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Oncolytic Virotherapy industry.
Key market trends defining the global Oncolytic Virotherapy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Oncolytic Virotherapy Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Oncolytic Virotherapy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Oncolytic Virotherapy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Oncolytic Virotherapy industry
Leading Oncolytic Virotherapy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Oncolytic Virotherapy companies.
Oncolytic Virotherapy Market Study- Strategic Analysis Review
The Oncolytic Virotherapy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Oncolytic Virotherapy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Oncolytic Virotherapy Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Oncolytic Virotherapy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Oncolytic Virotherapy market segments. Similarly, Strong market demand is encouraging Canadian Oncolytic Virotherapy companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Oncolytic Virotherapy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Oncolytic Virotherapy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Oncolytic Virotherapy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Oncolytic Virotherapy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Oncolytic Virotherapy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Oncolytic Virotherapy in Asia Pacific. In particular, China, India, and South East Asian Oncolytic Virotherapy markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Oncolytic Virotherapy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Oncolytic Virotherapy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Oncolytic Virotherapy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Oncolytic Virotherapy.
Oncolytic Virotherapy Market Company Profiles
The global Oncolytic Virotherapy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Amgen Inc, CG Oncology Inc, DNAtrix Inc, Lokon Pharma, Oncolys BioPharma Inc, Replimune Group Inc, Sorrento Therapeutics Inc, Targovax ASA, TILT Biotherapeutics Ltd, Transgene SA, VCN Biosciences, Vyriad Inc.
Recent Oncolytic Virotherapy Market Developments
The global Oncolytic Virotherapy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Oncolytic Virotherapy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Others
By Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Others
Geographical Segmentation:
Amgen Inc
CG Oncology Inc
DNAtrix Inc
Lokon Pharma
Oncolys BioPharma Inc
Replimune Group Inc
Sorrento Therapeutics Inc
Targovax ASA
TILT Biotherapeutics Ltd
Transgene SA
VCN Biosciences
Vyriad Inc
Formats Available: Excel, PDF, and PPT
With the increasing demand for innovative cancer treatments and personalized medicine, there is a rising interest in oncolytic viruses as a novel therapeutic approach to target and destroy cancer cells while sparing healthy tissue. Market growth is driven by factors such as expanding cancer incidence and prevalence, the rising investment in immuno-oncology research and development, and technological advancements in viral vector design and gene editing techniques. Additionally, the expanding applications of oncolytic virotherapy in solid tumors, hematological malignancies, and combination therapy regimens, as well as the growing number of clinical trials and regulatory approvals, contribute to market expansion. Further, the development of tumor-targeted viral vectors and immune-modulating strategies, the integration of oncolytic viruses into standard-of-care treatment protocols, and the emphasis on patient selection and biomarker-driven therapy are expected to further accelerate market growth in the coming years.
Oncolytic Virotherapy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Oncolytic Virotherapy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Oncolytic Virotherapy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Oncolytic Virotherapy industry.
Key market trends defining the global Oncolytic Virotherapy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Oncolytic Virotherapy Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Oncolytic Virotherapy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Oncolytic Virotherapy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Oncolytic Virotherapy industry
Leading Oncolytic Virotherapy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Oncolytic Virotherapy companies.
Oncolytic Virotherapy Market Study- Strategic Analysis Review
The Oncolytic Virotherapy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Oncolytic Virotherapy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Oncolytic Virotherapy Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Oncolytic Virotherapy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Oncolytic Virotherapy market segments. Similarly, Strong market demand is encouraging Canadian Oncolytic Virotherapy companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Oncolytic Virotherapy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Oncolytic Virotherapy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Oncolytic Virotherapy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Oncolytic Virotherapy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Oncolytic Virotherapy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Oncolytic Virotherapy in Asia Pacific. In particular, China, India, and South East Asian Oncolytic Virotherapy markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Oncolytic Virotherapy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Oncolytic Virotherapy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Oncolytic Virotherapy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Oncolytic Virotherapy.
Oncolytic Virotherapy Market Company Profiles
The global Oncolytic Virotherapy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Amgen Inc, CG Oncology Inc, DNAtrix Inc, Lokon Pharma, Oncolys BioPharma Inc, Replimune Group Inc, Sorrento Therapeutics Inc, Targovax ASA, TILT Biotherapeutics Ltd, Transgene SA, VCN Biosciences, Vyriad Inc.
Recent Oncolytic Virotherapy Market Developments
The global Oncolytic Virotherapy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Oncolytic Virotherapy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Others
By Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Amgen Inc
CG Oncology Inc
DNAtrix Inc
Lokon Pharma
Oncolys BioPharma Inc
Replimune Group Inc
Sorrento Therapeutics Inc
Targovax ASA
TILT Biotherapeutics Ltd
Transgene SA
VCN Biosciences
Vyriad Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Oncolytic Virotherapy Market Overview and Key Findings, 2024
1.2 Oncolytic Virotherapy Market Size and Growth Outlook, 2021- 2030
1.3 Oncolytic Virotherapy Market Growth Opportunities to 2030
1.4 Key Oncolytic Virotherapy Market Trends and Challenges
1.4.1 Oncolytic Virotherapy Market Drivers and Trends
1.4.2 Oncolytic Virotherapy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Oncolytic Virotherapy Companies
2. ONCOLYTIC VIROTHERAPY MARKET SIZE OUTLOOK TO 2030
2.1 Oncolytic Virotherapy Market Size Outlook, USD Million, 2021- 2030
2.2 Oncolytic Virotherapy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ONCOLYTIC VIROTHERAPY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ONCOLYTIC VIROTHERAPY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Others
By Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Oncolytic Virotherapy Market, 2025
5.2 Asia Pacific Oncolytic Virotherapy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Oncolytic Virotherapy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Oncolytic Virotherapy Market, 2025
5.5 Europe Oncolytic Virotherapy Market Size Outlook by Type, 2021- 2030
5.6 Europe Oncolytic Virotherapy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Oncolytic Virotherapy Market, 2025
5.8 North America Oncolytic Virotherapy Market Size Outlook by Type, 2021- 2030
5.9 North America Oncolytic Virotherapy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Oncolytic Virotherapy Market, 2025
5.11 South America Pacific Oncolytic Virotherapy Market Size Outlook by Type, 2021- 2030
5.12 South America Oncolytic Virotherapy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Oncolytic Virotherapy Market, 2025
5.14 Middle East Africa Oncolytic Virotherapy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Oncolytic Virotherapy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Oncolytic Virotherapy Market Size Outlook and Revenue Growth Forecasts
6.2 US Oncolytic Virotherapy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Oncolytic Virotherapy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Oncolytic Virotherapy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Oncolytic Virotherapy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Oncolytic Virotherapy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Oncolytic Virotherapy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Oncolytic Virotherapy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Oncolytic Virotherapy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Oncolytic Virotherapy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Oncolytic Virotherapy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Oncolytic Virotherapy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Oncolytic Virotherapy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Oncolytic Virotherapy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Oncolytic Virotherapy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Oncolytic Virotherapy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Oncolytic Virotherapy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Oncolytic Virotherapy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Oncolytic Virotherapy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Oncolytic Virotherapy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Oncolytic Virotherapy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Oncolytic Virotherapy Industry Drivers and Opportunities
7. ONCOLYTIC VIROTHERAPY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ONCOLYTIC VIROTHERAPY COMPANY PROFILES
8.1 Profiles of Leading Oncolytic Virotherapy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Amgen Inc
CG Oncology Inc
DNAtrix Inc
Lokon Pharma
Oncolys BioPharma Inc
Replimune Group Inc
Sorrento Therapeutics Inc
Targovax ASA
TILT Biotherapeutics Ltd
Transgene SA
VCN Biosciences
Vyriad Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Oncolytic Virotherapy Market Overview and Key Findings, 2024
1.2 Oncolytic Virotherapy Market Size and Growth Outlook, 2021- 2030
1.3 Oncolytic Virotherapy Market Growth Opportunities to 2030
1.4 Key Oncolytic Virotherapy Market Trends and Challenges
1.4.1 Oncolytic Virotherapy Market Drivers and Trends
1.4.2 Oncolytic Virotherapy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Oncolytic Virotherapy Companies
2. ONCOLYTIC VIROTHERAPY MARKET SIZE OUTLOOK TO 2030
2.1 Oncolytic Virotherapy Market Size Outlook, USD Million, 2021- 2030
2.2 Oncolytic Virotherapy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ONCOLYTIC VIROTHERAPY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ONCOLYTIC VIROTHERAPY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Others
By Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Oncolytic Virotherapy Market, 2025
5.2 Asia Pacific Oncolytic Virotherapy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Oncolytic Virotherapy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Oncolytic Virotherapy Market, 2025
5.5 Europe Oncolytic Virotherapy Market Size Outlook by Type, 2021- 2030
5.6 Europe Oncolytic Virotherapy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Oncolytic Virotherapy Market, 2025
5.8 North America Oncolytic Virotherapy Market Size Outlook by Type, 2021- 2030
5.9 North America Oncolytic Virotherapy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Oncolytic Virotherapy Market, 2025
5.11 South America Pacific Oncolytic Virotherapy Market Size Outlook by Type, 2021- 2030
5.12 South America Oncolytic Virotherapy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Oncolytic Virotherapy Market, 2025
5.14 Middle East Africa Oncolytic Virotherapy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Oncolytic Virotherapy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Oncolytic Virotherapy Market Size Outlook and Revenue Growth Forecasts
6.2 US Oncolytic Virotherapy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Oncolytic Virotherapy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Oncolytic Virotherapy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Oncolytic Virotherapy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Oncolytic Virotherapy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Oncolytic Virotherapy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Oncolytic Virotherapy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Oncolytic Virotherapy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Oncolytic Virotherapy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Oncolytic Virotherapy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Oncolytic Virotherapy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Oncolytic Virotherapy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Oncolytic Virotherapy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Oncolytic Virotherapy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Oncolytic Virotherapy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Oncolytic Virotherapy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Oncolytic Virotherapy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Oncolytic Virotherapy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Oncolytic Virotherapy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Oncolytic Virotherapy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Oncolytic Virotherapy Industry Drivers and Opportunities
7. ONCOLYTIC VIROTHERAPY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ONCOLYTIC VIROTHERAPY COMPANY PROFILES
8.1 Profiles of Leading Oncolytic Virotherapy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Amgen Inc
CG Oncology Inc
DNAtrix Inc
Lokon Pharma
Oncolys BioPharma Inc
Replimune Group Inc
Sorrento Therapeutics Inc
Targovax ASA
TILT Biotherapeutics Ltd
Transgene SA
VCN Biosciences
Vyriad Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
